Gormley Kelly, Dong Yanbin, Sagnella Giuseppe A
Division of Neurosciences, St. George's Hospital Medical School, Cranmer Terrace, London SW17 0RE, UK.
Biochem J. 2003 Apr 1;371(Pt 1):1-14. doi: 10.1042/BJ20021375.
The epithelial sodium channel (ENaC) is of fundamental importance in the control of sodium fluxes in epithelial cells. Modulation of sodium reabsorption through the distal nephron ENaC is an important component in the overall control of sodium balance, blood volume and thereby of blood pressure. This is clearly demonstrated by rare genetic disorders of sodium-channel activity (Liddle's syndrome and pseudohypoaldosteronism type 1), associated with contrasting effects on blood pressure. The mineralocorticoid aldosterone is a well-established modulator of sodium-channel activity. Considerable insight has now been gained into the intracellular signalling pathways linking aldosterone-mediated changes in gene transcription with changes in ion transport. Activating pathways include aldosterone-induced proteins and especially the serum- and glucocorticoid-inducible kinase (SGK) and the small G-protein, K-Ras 2A. Targeting of the ENaC for endocytosis and degradation is now emerging as a major mechanism for the down-regulation of channel activity. Several proteins acting in concert are an intrinsic part of this process but Nedd4 (neural precursor cell expressed developmentally down-regulated 4) is of central importance. Other mechanisms known to interact with ENaC and affect sodium transport include channel-activating protease 1 (CAP-1), a membrane-anchored protein, and the cystic fibrosis transmembrane regulator. The implications of research on accessory factors controlling ENaC activity are wide-ranging. Understanding cellular mechanisms controlling ENaC activity may provide a more detailed insight not only of ion-channel abnormalities in cystic fibrosis but also of the link between abnormal renal sodium transport and essential hypertension.
上皮钠通道(ENaC)在控制上皮细胞钠通量方面至关重要。通过远端肾单位ENaC调节钠重吸收是钠平衡、血容量乃至血压整体控制中的一个重要组成部分。钠通道活性的罕见遗传疾病(利德尔综合征和1型假性醛固酮增多症)对血压有相反的影响,这清楚地证明了这一点。盐皮质激素醛固酮是一种公认的钠通道活性调节剂。目前,人们对将醛固酮介导的基因转录变化与离子转运变化联系起来的细胞内信号通路有了相当深入的了解。激活途径包括醛固酮诱导蛋白,尤其是血清和糖皮质激素诱导激酶(SGK)和小G蛋白K-Ras 2A。将ENaC靶向内吞和降解正逐渐成为通道活性下调的主要机制。几种协同作用的蛋白质是这一过程的固有组成部分,但Nedd4(神经前体细胞表达的发育下调蛋白4)至关重要。已知与ENaC相互作用并影响钠转运的其他机制包括通道激活蛋白酶1(CAP-1),一种膜锚定蛋白,以及囊性纤维化跨膜调节因子。对控制ENaC活性的辅助因子的研究具有广泛的意义。了解控制ENaC活性的细胞机制不仅可以更详细地洞察囊性纤维化中的离子通道异常,还可以洞察异常肾钠转运与原发性高血压之间的联系。